Profil
Joan Mannick was the founder of resTORbio, Inc. which was founded in 2016, where she held the title of Chief Medical Officer from 2017 to 2020.
She is also the founder of Tornado Therapeutics, Inc. Dr. Mannick's former jobs include being the Medical Director at Genzyme Corp.
from 2007 to 2010 and the Executive Director-New Indications Discovery Unit at Novartis Institutes of Biomedical Research from 2010 to 2017.
Dr. Mannick received her doctorate from Harvard Medical School and her undergraduate degree from Harvard College.
Postes actifs de Joan Mannick
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Joan Mannick
| Sociétés | Poste | Fin |
|---|---|---|
| ADICET BIO, INC. | Fondateur | 14/09/2020 |
Novartis Institutes of Biomedical Research
 Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Corporate Officer/Principal | 01/03/2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/01/2010 |
Formation de Joan Mannick
| Harvard College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
Novartis Institutes of Biomedical Research
Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Novartis Institutes of Biomedical Research operates a pharmaceutical research organization. The private company is based in Emeryville. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
